● From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
● The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
● Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
● The firm trades with high earnings multiples: 29.72 times its 2024 earnings per share.
● The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
● For the past year, analysts have significantly revised downwards their profit estimates.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● Over the past twelve months, analysts' opinions have been revised negatively.
● The company's earnings releases usually do not meet expectations.